Literature DB >> 10640793

Cholesterol paradox in patients with paroxysmal atrial fibrillation.

M Annoura1, M Ogawa, K Kumagai, B Zhang, K Saku, K Arakawa.   

Abstract

Hypercholesterolemia is a major risk factor for coronary heart disease (CHD), but the associations among lipids, lipoproteins and paroxysmal atrial fibrillation (PAF) have not yet been reported. The associations among lipids, lipoproteins and PAF were examined in a case-control study, in which cases and controls were defined as those with/without definite ECG-detectable PAF, respectively. CHD patients were excluded from the study. The mean values of serum total cholesterol (TC), triglyceride (TG) and high density lipoprotein-cholesterol (HDL-C), after adjusting for age and gender, in patients with PAF were lower than those in patients without PAF (175 +/- 4 mg/dl vs. 190 +/- 3 mg/dl, 104 +/- 7 mg/dl vs. 123 +/- 6 mg/dl, 46.0 +/- 1.7 mg/dl vs. 51.8 +/- 1.4 mg/dl, respectively), as assessed by an analysis of covariance. After controlling for age and gender, TC, TG and HDL-C (all in quartiles) were inversely and linearly (p < 0.05) associated with the percentage of patients with PAF, as assessed by a multiple logistic regression analysis. The associations between TC or TG and PAF varied with the HDL-C level: significant when HDL-C was low (p < 0.05), but not when HDL-C was high. The odds ratio (relative risk of PAF) for patients with both low TC or TG and low HDL-C was 4.08 (95% CI: 1.81-9.57) times or 9. 40 (3.25-32.0) times higher (p < 0.01) than that for patients with high TC or TG and high HDL-C, respectively. In conclusion, low serum levels of TC and TG were found in PAF patients, while reduced HDL-C may cause PAF. Hypolipoproteinemia including low HDL-C may affect atrial vulnerability and cause atrial fibrillation. Copyright 2000 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10640793     DOI: 10.1159/000006942

Source DB:  PubMed          Journal:  Cardiology        ISSN: 0008-6312            Impact factor:   1.869


  26 in total

1.  Paradoxical association of lipoprotein measures with incident atrial fibrillation.

Authors:  Samia Mora; Akintunde O Akinkuolie; Roopinder K Sandhu; David Conen; Christine M Albert
Journal:  Circ Arrhythm Electrophysiol       Date:  2014-05-25

2.  Lipid profile and incidence of atrial fibrillation: A prospective cohort study in China.

Authors:  Xintao Li; Lianjun Gao; Zhao Wang; Bo Guan; Xumin Guan; Binhao Wang; Xu Han; Xianjie Xiao; Khalid Bin Waleed; Clarance Chandran; Shouling Wu; Yunlong Xia
Journal:  Clin Cardiol       Date:  2018-03-25       Impact factor: 2.882

3.  Atrial fibrillation and diabetes mellitus. Correlation, co-existence, and coagulation therapy.

Authors:  B Stratmann; D Tschöpe
Journal:  Herz       Date:  2012-05       Impact factor: 1.443

4.  Association of the metabolic syndrome with atrial fibrillation among United States adults (from the REasons for Geographic and Racial Differences in Stroke [REGARDS] Study).

Authors:  Rikki M Tanner; Usman Baber; April P Carson; Jenifer Voeks; Todd M Brown; Elsayed Z Soliman; Virginia J Howard; Paul Muntner
Journal:  Am J Cardiol       Date:  2011-04-29       Impact factor: 2.778

5.  Blood lipid levels and recurrence of atrial fibrillation after radiofrequency catheter ablation: a prospective study.

Authors:  Yunpeng Shang; Nan Chen; Qiqi Wang; Chengui Zhuo; Jianqiang Zhao; Ning Lv; Yuan Huang
Journal:  J Interv Card Electrophysiol       Date:  2019-04-07       Impact factor: 1.900

6.  Association between serum apolipoprotein B and atrial fibrillation: a case-control study.

Authors:  Xia Zhong; Huachen Jiao; Dongsheng Zhao; Jing Teng
Journal:  Sci Rep       Date:  2022-06-10       Impact factor: 4.996

Review 7.  Atrial Fibrillation and Its Association with Endocrine Disorders.

Authors:  Manjari Devidi; Avanija Buddam; Sunil Dacha; D Sudhaker Rao
Journal:  J Atr Fibrillation       Date:  2014-02-28

Review 8.  Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanism.

Authors:  Beatrice A Golomb; Marcella A Evans
Journal:  Am J Cardiovasc Drugs       Date:  2008       Impact factor: 3.571

9.  Impact of duration and dosage of statin treatment and epicardial fat thickness on the recurrence of atrial fibrillation after electrical cardioversion.

Authors:  Kyoung-Im Cho; Bong-Joon Kim; Tae-Joon Cha; Jung-Ho Heo; Hyun-Su Kim; Jae-Woo Lee
Journal:  Heart Vessels       Date:  2014-04-02       Impact factor: 2.037

10.  Usefulness of the American Heart Association's Life Simple 7 to Predict the Risk of Atrial Fibrillation (from the REasons for Geographic And Racial Differences in Stroke [REGARDS] Study).

Authors:  Parveen K Garg; Wesley T O'Neal; Adedotun Ogunsua; Evan L Thacker; George Howard; Elsayed Z Soliman; Mary Cushman
Journal:  Am J Cardiol       Date:  2017-10-19       Impact factor: 2.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.